|
CRON | Cronos Group Inc. |
|
|
CRON | Cronos Group Inc. |
| Medicinal Chemicals & Botanical Products |
| Book value per $ invested | $ 0.97 |
| Leverage | 3.93% |
| Market Cap | $ 1.2B |
| PE | 32.82 |
| Dividend Yield | 0.00% |
| Profit | $ 35.4m |
| Margin | 26.82% |
Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada.